These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3874027)

  • 61. IgG anti-cardiolipin antibodies in murine lupus.
    Gharavi AE; Mellors RC; Elkon KB
    Clin Exp Immunol; 1989 Nov; 78(2):233-8. PubMed ID: 12412755
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liver is a possible site for the proliferation of abnormal CD3+4-8- double-negative lymphocytes in autoimmune MRL-lpr/lpr mice.
    Ohteki T; Seki S; Abo T; Kumagai K
    J Exp Med; 1990 Jul; 172(1):7-12. PubMed ID: 2141631
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    Watanabe H; Garnier G; Circolo A; Wetsel RA; Ruiz P; Holers VM; Boackle SA; Colten HR; Gilkeson GS
    J Immunol; 2000 Jan; 164(2):786-94. PubMed ID: 10623824
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Murine complement-mediated immune clearance dysfunction is associated with the lymphoproliferative (lpr) gene.
    Meryhew NL; Messner RP
    Clin Immunol Immunopathol; 1993 Dec; 69(3):324-32. PubMed ID: 8242904
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oncogene expression in autoimmune mice.
    Mountz JD; Mushinski JF; Mark GE; Steinberg AD
    J Mol Cell Immunol; 1985; 2(3):121-31. PubMed ID: 3916923
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Different expression of T-cell receptor beta-chain variable region genes in lymph nodes of lpr mice with different alleles of the major histocompatibility complex.
    Ohga S; Yoshikai Y; Kishihara K; Matsuzaki G; Ogimoto M; Nomoto K
    Immunology; 1990 Jun; 70(2):216-22. PubMed ID: 2373519
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The tissue specific elevation in synthesis of the 90 kDa heat shock protein precedes the onset of disease in lupus prone MRL/lpr mice.
    Faulds GB; Isenberg DA; Latchman DS
    J Rheumatol; 1994 Feb; 21(2):234-8. PubMed ID: 8182630
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An MRL/MpJ-lpr/lpr substrain with a limited expansion of lpr double-negative T cells and a reduced autoimmune syndrome.
    Fossati L; Takahashi S; Merino R; Iwamoto M; Aubry JP; Nose M; Spach C; Motta R; Izui S
    Int Immunol; 1993 May; 5(5):525-32. PubMed ID: 8318455
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis.
    Yoshida H; Yoshida M; Izui S; Lambert PH
    J Clin Invest; 1985 Aug; 76(2):685-94. PubMed ID: 3875630
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Specificity of monoclonal anti-Z-DNA antibodies from unimmunized MRL/Mp-lpr/lpr mice.
    Bergen HR; Losman MJ; O'Connor T; Zacharias W; Larson JE; Accavitti MA; Wells RD; Koopman WJ
    J Immunol; 1987 Aug; 139(3):743-8. PubMed ID: 3496387
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice.
    Weinberg JB
    Environ Health Perspect; 1998 Oct; 106 Suppl 5(Suppl 5):1131-7. PubMed ID: 9788887
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).
    Karussis DM; Vourka-Karussis U; Lehmann D; Abramsky O; Ben-Nun A; Slavin S
    Clin Exp Immunol; 1995 Apr; 100(1):111-7. PubMed ID: 7697909
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study.
    Hess DC; Taormina M; Thompson J; Sethi KD; Diamond B; Rao R; Chamberlain CR; Feldman DS
    J Rheumatol; 1993 Apr; 20(4):610-7. PubMed ID: 8496852
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term treatment with 5,5-diphenylhydantoin reduces lymphadenopathy and anti-ssDNA autoantibodies in C57BL/6-lpr/lpr mice.
    Bloksma N; de Bakker JM; van Rooijen HJ; Punt P; Seinen W; Kammüller ME
    Int J Immunopharmacol; 1994 Mar; 16(3):261-8. PubMed ID: 8206693
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetic basis of autoimmune disease in MRL/lpr mice: dissection of the complex pathological manifestations and their susceptibility loci.
    Nose M; Nishihara M; Kamogawa J; Terada M; Nakatsuru S
    Rev Immunogenet; 2000; 2(1):154-64. PubMed ID: 11324688
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The anti-La response of a single MRL/Mp-lpr/lpr mouse: specificity for DNA and VH gene usage.
    Bloom DD; St Clair EW; Pisetsky DS; Clarke SH
    Eur J Immunol; 1994 Jun; 24(6):1332-8. PubMed ID: 8206093
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Spontaneous elaboration of transforming growth factor beta suppresses host defense against bacterial infection in autoimmune MRL/lpr mice.
    Lowrance JH; O'Sullivan FX; Caver TE; Waegell W; Gresham HD
    J Exp Med; 1994 Nov; 180(5):1693-703. PubMed ID: 7964455
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Nephritogenic antibodies in MRL/lpr lupus mice: molecular characteristics in pathological and genetic aspects.
    Itoh J; Takahashi S; Ono M; Yamamoto T; Nose M; Kyogoku M
    Tohoku J Exp Med; 1994 May; 173(1):65-74. PubMed ID: 7809912
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains.
    Warren RW; Caster SA; Roths JB; Murphy ED; Pisetsky DS
    Clin Immunol Immunopathol; 1984 Apr; 31(1):65-77. PubMed ID: 6607806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.